Theator Achieves HITRUST CSF® Certification for Ensuring the Highest Standards of Privacy and Compliance to Partner Healthcare Institutions

Theator, the creator of Surgical Intelligence, announced today that it has achieved the HITRUST Cyber Security Framework (CSF) certification for practicing security protocols that meet both risk- and compliance-based HITRUST CSF requirements.

HITRUST CSF is a certifiable framework that provides organizations with a comprehensive, flexible, and efficient approach to regulatory compliance and risk management. Due to the sensitive nature of healthcare data specifically and the rise in healthcare breaches this year, HITRUST CSF certification is essential for health technology vendors to instill confidence in security measures and protect the very patients they aim to help. This accomplishment demonstrates the high level of importance Theator places on privacy, security, and compliance and solidifies Theator as a leader in all three areas. With HITRUST CSF certification, Theator is committed to maintaining the highest levels of nationally and internationally accepted security and privacy-related regulatory adherence in ongoing and future projects.

“Surgical Intelligence increases visibility into the OR to better evaluate surgical best practices, so we, at Theator, have a responsibility to provide our partners and their patients with the highest levels of protection,” said Dotan Asselmann, CTO and Co-founder of Theator. “HITRUST CSF certification instills that confidence in Theator’s technology and accelerates our mission to define a new gold standard in surgical care.”

Theator created the category of Surgical Intelligence to increase OR visibility and eliminate the widespread variability and disparity plaguing the surgical field. Theator’s first-of-its-kind Surgical Intelligence Platform institutionalizes automatic and routine surgical video capture, layering footage with AI-powered analysis of every operation. Surgical stakeholders access actionable insights to deliver optimized patient outcomes, ultimately enhancing surgical best practices and raising overall standards of care.

Most recently, in July 2022, Theator announced it had closed out its Series A funding with $39.5M, having now raised a total of $42.5M. In the last year, Theator has collaborated with Mayo Clinic and partnered with the Canadian Association of General Surgeons (CAGS), adding further prestige to the burgeoning list of innovative medical institutions and surgical societies adopting Surgical Intelligence. Last December, the company was named on CB Insights’ prestigious Digital Health 150 list of the 150 most innovative digital health startups in the world, highlighting industry recognition of Surgical Intelligence as a distinct category for the first time.

SourceTheator

Hot this week

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.